- Global Pharma News & Resources

Golden State Urology Announces Dr. Prithipal Sethi's Designation as UroLift® Center of Excellence

Golden State Urology Announces Dr. Prithipal Sethi's Designation as UroLift® Center of Excellence Designation Recognizes Dr. Prithipal Sethi's Commitment to Exemplary Care, Deep UroLift Experience

PR Newswire

SACRAMENTO, Calif., Nov. 20, 2018

SACRAMENTO, Calif., Nov. 20, 2018 /PRNewswire-PRWeb/ -- Golden State Urology today announced that Dr. Prithipal Sethi has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Sethi has achieved a high level of training and experience with the UroLift System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia or BPH.

"With the UroLift System, symptoms of benign prostatic hyperplasia can be treated with a state of art system that provides rapid improvement of symptoms with the ability to wean off long-term medications. This minimally invasive therapy is definitely on its way to becoming the new standard of care for BPH," said Dr. Sethi

Nearly 40 million men in the United States are affected by BPH. Not to be confused with prostate cancer, BPH occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems, and can cause loss of productivity, depression and decreased quality of life.

Five-year data from a randomized study shows the UroLift System offers not only rapid improvement, but also durable relief for patients with BPH. After five years, patients treated with the UroLift System continue to experience symptom relief with minimal side effects, with few patients requiring an additional procedure for relief. A second randomized clinical trial called BPH6 demonstrated that the minimally invasive UroLift System compares very well to the reference standard surgery, transurethral resection of the prostate (TURP), with regard to efficacy, and is superior to TURP at preserving sexual function and offering a more rapid recovery.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation.

About the UroLift System
NeoTract's FDA-cleared UroLift System is a novel, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at

About Golden State Urology and Dr Sethi
Golden State Urology has offices located in Stockton, Lodi, Elk Grove and Sacramento and offers a wide range of services for men and women. Our physicians are dedicated to excellent patient care and experts in the latest care techniques. Our staff is knowledgeable and helpful, and our offices are friendly and warm.

Dr. Prithipal Sethi received his Bachelors of Science degree from University of California Berkeley in Cell and Molecular Biology. He received his medical degree from St. Louis University School of Medicine and completed his residency at Medical College of Wisconsin. He is board certified by the American Board of Urology.

Dr. Sethi started his Urology career in Stockton in 2004. He founded Golden State Urology in 2007 and which has since expanded to include more locations to help provide care to patients residing in Manteca, Stockton, Lodi and Sacramento. Dr. Sethi's expertise and continued interest in advanced technologies has allowed him to introduce novel treatments to the area. Currently, his practice provides comprehensive services in urological conditions including Prostate Cancer, BPH, Kidney Stones, male and female Incontinence and Erectile Dysfunction. The practice also offers in-house dispensing and path lab services for the convenience of the patient. Golden State Urology was awarded Best of Stockton Awards in the category of Urologist 2018.

Dr. Sethi is a member of the American Urological Association, American Urological Association Western Section, San Joaquin Medical Society, St Louis University Alumni Association and Medical College of Wisconsin Alumni Association.

# # #



Editor Details

  • Company:
    • PR Newswire
  • Website:
Last Updated: 20-Nov-2018